Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Bruker Corp (BRKR)

Bruker Corp (BRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BRKR
3 Reasons to Sell BRKR and 1 Stock to Buy Instead StockStory - Sun Jul 26, 11:03PM CDT

3 Reasons to Sell BRKR and 1 Stock to Buy Instead

BRKR : 61.74 (-1.86%)
Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast Business Wire - Fri Jul 24, 3:01PM CDT

Bruker Corporation (Nasdaq: BRKR) today announced it will report second quarter 2026 financial results before market opening on Tuesday, August 4, 2026. The Company will host a conference call...

BRKR : 61.74 (-1.86%)
Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood Business Wire - Wed Jul 15, 6:00AM CDT

Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of the DISQVER ® clinical metagenomics platform from Noscendo GmbH. This press release features...

BRKR : 61.74 (-1.86%)
TNL
3 Cash-Producing Stocks We’re Skeptical Of StockStory - Mon Jul 13, 11:36PM CDT

3 Cash-Producing Stocks We’re Skeptical Of

TNL : 77.71 (-0.94%)
BLDR : 67.76 (-8.03%)
BRKR : 61.74 (-1.86%)
BRKR
Bruker (BRKR) Stock Trades Up, Here Is Why StockStory - Thu Jun 25, 11:06AM CDT

Bruker (BRKR) Stock Trades Up, Here Is Why

BRKR : 61.74 (-1.86%)
MarketBeat.com
Bruker Signals Growth Pivot as Semiconductor and Overseas Orders Gain Steam MarketBeat - Sat Jun 6, 3:02PM CDT

Bruker (NASDAQ:BRKR) is seeing stronger order momentum across several end markets, with semiconductor metrology, non-U.S. academic and government customers, and parts of its diagnostics business helping...

BRKR : 61.74 (-1.86%)
Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026 Business Wire - Thu Jun 4, 6:00AM CDT

At ASM Microbe 2026, Bruker Corporation’s (Nasdaq: BRKR) Microbiology & Infection Diagnostics (BMID) division is demonstrating its expanding portfolio and innovations across microbial...

BRKR : 61.74 (-1.86%)
FIGS
3 Small-Cap Stocks That Concern Us StockStory - Tue Jun 2, 11:31PM CDT

3 Small-Cap Stocks That Concern Us

TCBI : 98.42 (-0.29%)
BRKR : 61.74 (-1.86%)
FIGS : 10.56 (+2.23%)
Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry Business Wire - Tue Jun 2, 10:24AM CDT

At ASMS, Bruker Corporation (Nasdaq: BRKR) announced the launch of the new timsMRMS system, designed to empower researchers in petroleomics, sustainable fuels and advanced...

BRKR : 61.74 (-1.86%)
Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease Biology Business Wire - Mon Jun 1, 6:00AM CDT

Bruker Also Launches Two Novel Mass Spectrometry Systems for Unique Applications in Energy Industry Research, and in Semiconductor Manufacturing ...

BRKR : 61.74 (-1.86%)

Barchart Exclusives

This Dividend Stock Is Up 22% in a Month Despite Mixed Q2 Earnings. Don’t Sell Just Yet. Barchart - Wed Jul 29, 6:30PM CDT
Domino’s Pizza stock has rebounded sharply from its 2026 lows. While its valuation multiples have expanded and DPZ does not look as tempting now, dividend investors can stay put in the stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.